[1]
Ciniero, G., Gentile, F., Elmenoufy, A.H., Cros-Perrial, E. , West, F.G., Weinfeld, M., Deriu, M.A., Jordheim, L.P. and Tuszynski, J.A. 2021. Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity. Biomedical Science and Engineering. 2, 1 (Sep. 2021). DOI:https://doi.org/10.4081/bse.164.